Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Assets
Cash	$ 243,294	$ 289,925
Cash collateral posted to counterparties	306,104	263,799
Agency Securities, available for sale, at fair value (including pledged securities of $10,208,822 at March 31, 2016 and $12,109,868 at December 31, 2015)	10,474,010	12,461,556
Non-Agency Securities, trading, at fair value (including pledged securities of $269,855 at March 31, 2016 and $0 at December 31, 2015)	285,696	0
Derivatives, at fair value	1,665	999
Principal payments receivable	0	37
Accrued interest receivable	28,883	34,500
Prepaid and other	4,382	4,461
Total Assets	11,344,034	13,055,277
Liabilities:
Repurchase agreements	9,923,859	11,570,481
Payable for unsettled purchases	14,955	0
Derivatives, at fair value	298,685	233,301
Accrued interest payable- repurchase agreements	6,255	7,724
Accounts payable and other accrued expenses	4,645	18,605
Total Liabilities	$ 10,248,399	$ 11,830,111
Commitments and contingencies
Preferred stock, $0.001 par value, 50,000 shares authorized;
Common stock, $0.001 par value, 125,000 shares authorized, 36,692 and 36,682 shares issued and outstanding at March 31, 2016 and December 31, 2015	$ 37	$ 37
Additional paid-in capital	2,559,582	2,559,361
Accumulated deficit	(1,586,711)	(1,266,938)
Accumulated other comprehensive income (loss)	122,719	(67,302)
Total Stockholders’ Equity	1,095,635	1,225,166
Total Liabilities and Stockholders’ Equity	11,344,034	13,055,277
Series A Preferred Stock
Preferred stock, $0.001 par value, 50,000 shares authorized;
Preferred stock	2	2
Series B Preferred Stock
Preferred stock, $0.001 par value, 50,000 shares authorized;
Preferred stock	$ 6	$ 6